PubMed,
Journal Year:
2024,
Volume and Issue:
49(8), P. 1353 - 1362
Published: Aug. 28, 2024
Renal
fibrosis
is
the
common
pathological
basis
for
progressive
development
of
chronic
kidney
disease
(CKD)
caused
by
various
etiologies.
It
characterized
persistent
deposition
extracellular
matrix,
leading
to
renal
tissue
damage
and
impaired
function,
ultimately
progressing
failure.
Current
clinical
treatments
CKD
mainly
focus
on
managing
primary
diseases,
with
no
specific
drugs
targeting
fibrosis.
The
pathogenesis
complex,
there
are
currently
available
reverse
it.
A
comprehensive
overview
fibrosis,
alongside
a
summary
current
anti-fibrotic
therapies,
including
some
that
already
used
clinically
slow
function
progression,
new
in
trials,
emerging
targeted
could
provide
theoretical
foundations
perspectives
treatment
Phytomedicine Plus,
Journal Year:
2024,
Volume and Issue:
4(2), P. 100537 - 100537
Published: Feb. 20, 2024
:
Attributes
of
potential
targets
for
anticancer
therapy
are
currently
being
investigated
telomeres,
telomerase,
and
their
combined
complex.
Telomerase
(TRTase)
is
a
distinct
reverse
transcriptase
that
thought
to
be
the
leader
in
almost
all
cancer-derived
cells
primarily
charge
controlling
telomere
(TLM)
length.
This
enzyme
therefore
guarantees
unabated
cell
division
during
carcinogenesis,
characteristic
cancer,
this
distinguishing
factor
has
made
TRTase
spotlight
target
pharmaceutical
research
cancer
therapy.
The
capacity
nutraceuticals
inhibit
TRTase,
impair
TLMs,
hinder
complex
formation
offers
window
opportunity
discovery
new
cancer-treatment
targets.
review
attempts
provide
fundamental
understanding
TLM
investigation,
regulatory
frameworks,
diverse
binding
proteins
TLM-TRTase
structure.
Moreover,
study
highlights
address
inhibition
at
molecular
level,
inhibitors
catalytic
subunits.
thorough
knowledge
TRTase's
physiological
action
will
offer
crucial
information
boosting
effectiveness
plausible
chemotherapeutic
drug
designs.
Frontiers in Medicine,
Journal Year:
2025,
Volume and Issue:
11
Published: Jan. 17, 2025
This
study
analyzed
literature
on
traditional
Chinese
medicine
(TCM)
in
treating
chronic
kidney
disease
(CKD)
to
identify
research
trends
and
provide
guidance
for
future
studies
clinical
practice.
The
used
data
from
Web
of
Science
2000
2024
analyze
English-language
CKD
TCM.
Bibliometric
analysis
was
done
using
R
software
the
bibliometric
package,
with
scientific
mapping
visualization
conducted
tools
like
Citespace,
VOSviewer,
ScimagoGraphica
explore
connections.
revealed
that
a
total
1,153
relevant
documents
were
retrieved,
number
published
articles
showed
an
increasing
trend,
reaching
peak
2022.
In
terms
article
publication,
China
ranked
first
760
articles,
closely
followed
by
United
States
132
articles.
Guangzhou
University
Traditional
Medicine
60
papers,
most
among
academic
institutions,
Shanghai
54
papers.
individual
authors,
Liu
Xinhui
holds
record
highest
totaling
17,
Li
Ping
Shunmin.
prevalent
keywords
include
"chronic
disease,"
"TCM,"
"oxidative
stress."
Currently,
prominent
areas
interest
network
pharmacology,
gut
microbiota,
oxidative
stress,
related
topics.
current
trend
this
field
is
towards
adoption
novel
methodologies
such
as
pharmacology
emphasis
exploring
relationship
between
microbiota
CKD.
Global
TCM
treatment
showing
positive
development
but
further
safety,
efficacy
evaluation,
international
cooperation
still
needed.
adopt
new
methods
focus
mechanism
Integrative Medicine in Nephrology and Andrology,
Journal Year:
2025,
Volume and Issue:
12(1)
Published: Jan. 30, 2025
Quercetin
is
a
natural
flavonoid
found
in
variety
of
herbs
and
the
main
active
ingredient
several
herbal
formulas
for
treating
kidney
disease.
Numerous
studies
have
shown
that
quercetin
can
effectively
attenuate
acute
injury
(AKI)
by
inhibiting
renal
inflammation,
ferroptosis,
cell
apoptosis.
ameliorates
fibrosis
chronic
disease
(CKD)
attenuating
epithelial-to-mesenchymal
transition,
cellular
senescence,
other
mechanisms.
Therefore,
may
be
potential
drug
treatment
diseases.
In
this
review,
recent
advances
therapeutic
effects
on
mechanisms
AKI
CKD
are
discussed.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 21, 2025
Berberine
(BBR)
is
a
pentacyclic
benzylisoquinoline
alkaloid
widely
distributed
across
various
medicinal
plants.
Recent
studies
have
demonstrated
that
berberine
possesses
broad
spectrum
of
pharmacological
activities,
including
not
only
antioxidant
properties
but
also
the
ability
to
lower
blood
glucose,
modulate
lipid
profiles,
and
mitigate
inflammation.
These
findings
suggest
holds
significant
potential
as
therapeutic
agent
for
renal
diseases,
highlighting
its
substantial
research
value.
Moreover,
when
administered
orally,
has
been
shown
exhibit
wide
safety
margin.
Several
identified
berberine's
renoprotective
effects
range
kidney
disorders,
diabetic
nephropathy,
fibrosis,
aging,
toxicity
induced
by
chemotherapy
antibiotics.
underscore
evolving
both
acute
injury
(AKI)
chronic
disease
(CKD).
In
summary,
discussed
in
this
article
provides
comprehensive
overview
BBR
elucidates
molecular
mechanisms
underlying
treatment
disease.
Furthermore,
underscores
significance
promising
disorders.
Journal of Nanobiotechnology,
Journal Year:
2025,
Volume and Issue:
23(1)
Published: Feb. 28, 2025
This
study
explored
the
novel
mechanism
of
Astragaloside
IV
(As)
in
treating
sepsis
and
its
application
through
a
biomimetic
nano-delivery
system
(As@ZM).
Sepsis,
condition
organ
dysfunction
caused
by
an
abnormal
host
response
to
infection,
poses
significant
threat
global
health
due
high
mortality
rate.
Our
findings
revealed
new
for
As
sepsis,
which
involved
reduction
neutrophil
extracellular
traps
(NETs)
release,
potentially
related
binding
with
IκBα
inhibit
activation
NF-κB
pathway.
treated
neutrophils
also
improved
immune
microenvironment
crosstalk
endothelial
cells
lung
epithelial
cells.
However,
stability
bioavailability
limited
clinical
application.
To
address
this
issue,
we
had
developed
ZIF-8-based
that
achieved
targeted
delivery
membrane
coating,
significantly
enhancing
therapeutic
efficacy
As.
The
innovative
design
As@ZM
offered
strategy
treatment,
potential
improve
outcomes.
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: Feb. 28, 2025
Abstract
Purpose
Colorectal
cancer
(CRC)
is
the
third
most
common
globally,
necessitating
novel
biomarkers
for
early
diagnosis
and
treatment.
This
study
proposes
an
efficient
pipeline
leveraging
integrated
bioinformatics
machine
learning
framework
to
enhance
identification
of
diagnostic
prognostic
CRC.
Methods
A
selection
methylated
differentially
expressed
genes
(MeDEGs)
features
(genes)
was
made
using
both
statistical
Machine
(ML)
approaches
from
publically
available
datasets.
These
were
subjected
STRING
network
construction
hub
estimation,
separately.
Also,
essential
miRNAs
(micro-RNAs)
TFs
(Transcription
factors)
as
regulatory
elements
revealed
findings
validated
through
scRNA-seq
analysis,
promoter
methylation,
gene
expression
levels
correlated
with
pathological
stage,
interaction
tumor-infiltrating
immune
cells.
Results
Through
analysis
pipeline,
we
identified
27
genes,
among
which
CTNNB1,
GSK3B,
IL-1β,
MYC,
PXDN,
TP53,
EGFR,
SRC,
COL1A1,
TGBF1
showed
better
behaviour.
approach
includes
development
K-Nearest
Neighbors
(KNN),
Artificial
Neural
Networks
(ANN),
Random
Forest
(RF)
models
TCGA
datasets,
achieving
accuracy
range
between
99
100%.
The
Area
Under
Curve
(AUC)
value
each
model
1.00,
signifying
good
classification
performance.
high
some
associated
poor
prognosis,
concluding
IL-1β
a
biomarker.
Additionally,
NF-κB
microRNAs
(miR-548d-3p,
miR-548-ac)
(NFκB
STAT5A)
play
major
role
in
comprehensive
Furthermore,
such
TGFB1,
COL1A1
significantly
infiltrates,
suggesting
their
potential
CRC
progression.
Conclusion
Overall,
elevated
coupled
abnormal
DNA
its
consequent
effect
on
PI3K/Akt
signaling
pathway
are
relevant
therapeutic
marker
Additional
molecular
candidates
reveal
insights
into
epigenetic
targets
association
cell
infiltration.
Basic Research in Cardiology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 15, 2025
Abstract
Since
cell
dying
in
heart
failure
(HF)
may
vary
based
on
the
aetiology,
we
examined
main
forms
of
regulated
necrosis,
such
as
necroptosis
and
pyroptosis,
hearts
damaged
due
to
myocardial
infarction
(MI)
or
pressure
overload.
We
also
investigated
effects
a
drug
inhibiting
RIP3,
proposed
convergent
point
for
both
these
necrosis-like
death
modes.
In
rat
hearts,
left
ventricular
function,
remodelling,
pro-cell
death,
pro-inflammatory
events
were
investigated,
pharmacodynamic
action
RIP3
inhibitor
(GSK'872)
was
assessed.
Regardless
HF
cells
necroptosis,
albeit
upstream
signals
be
different.
Pyroptosis
observed
only
post-MI
HF.
The
dysregulated
miRNAs
accompanied
by
higher
levels
predicted
target,
HMGB1,
its
receptors
(TLRs),
well
exacerbation
inflammation
likely
originating
from
macrophages.
suppressed
unlike
normalised
tended
decrease
collagen
content
affect
macrophage
infiltration
without
affecting
cardiac
function
structure.
mitigated
local
circulating
HMGB1
rats
with
Elevated
serum
detected
patients
positively
correlated
C-reactive
protein,
highlighting
axis.
conclusion,
MI-,
but
not
overload-induced
HF,
pyroptosis
operate
might
underlie
pathogenesis.
RIP3-targeting
pharmacological
intervention
protect
preventing
pro-death
mechanisms,
however,
additional
strategies
targeting
multiple
pathways
exhibit
greater
cardioprotection.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: April 16, 2025
Renal
fibrosis
represents
the
terminal
pathological
manifestation
of
most
chronic
kidney
diseases,
driving
progressive
loss
renal
function.
Natural
products
have
emerged
as
promising
therapeutic
agents
for
preventing
and
ameliorating
due
to
their
multi-target
efficacy
favorable
safety
profiles.
In
this
review,
we
conducted
a
comprehensive
literature
search
on
PubMed
using
keywords
“natural
product”
“renal
fibrosis”
from
2004
2025,
identifying
704
relevant
articles.
We
systematically
categorize
discuss
biological
effects
key
natural
formulations
with
antifibrotic
potential,
focusing
five
major
classes:
glycosides,
flavonoids,
phenolic
compounds,
anthraquinones,
terpenoids.
Representative
compounds
each
category
are
highlighted
mechanisms
action,
including
modulation
oxidative
stress,
inflammation,
autophagy,
signaling
pathways.
This
review
aims
provide
theoretical
foundation
development
product-based
therapies
combat
fibrosis,
offering
insights
into
potential
future
research
directions.
Acupuncture and Herbal Medicine,
Journal Year:
2024,
Volume and Issue:
4(2), P. 184 - 196
Published: May 29, 2024
Ensuring
the
safety
of
traditional
Chinese
medicines
(TCM)
has
perennially
presented
a
universal
challenge
in
healthcare
realm.
Meticulous
investigations
into
toxicological
intricacies
natural
products
are
paramount
significance,
particularly
regarding
metabolic
transformation
these
substances
and
subsequent
generation
reactive
intermediates.
This
biochemical
process
underlies
genesis
diverse
toxic
manifestations,
including
hepatotoxicity,
nephrotoxicity,
pulmonary
toxicity,
genotoxicity.
Compounds
sorted
within
TCM,
pyrrolizidine
alkaloids,
anthraquinones,
furanoterpenoids,
alkenylbenzenes,
bisbenzylisoquinoline
flavonoids,
methylenedioxyphenyl
derivatives,
evince
spectrum
deleterious
mechanisms
upon
activation.
review
provides
comprehensive
delineation
pathways
through
which
compounds
induce
toxicity
via
emphasizes
chemical
involved
activation
that
may
trigger
cascade,
rather
than
superficial
phenomenon.
Furthermore,
this
study
enriches
extant
literature
by
delving
advancements
elucidating
engendered
In
conclusion,
highlights
importance
scrutinizing
insights
judicious
safe
use
TCM.